HealthSquare.com

Your Prescription Drug Destination
See all our sites for your special health needs at www.HealthCentral.com

Feiba VH Immuno IV

Generic Name: ANTI-INHIBITOR COAGULANT COMPLEX - INJECTION
Pronounced: (an-tee-in-HIB-eh-turr ko-AGG-you-lunt KOM-plex)

Feiba VH Immuno IV Uses

This medication is used to treat patients with certain blood-clotting conditions (hemophilia with inhibitors) before surgery or during an attack of bleeding. People with these blood-clotting conditions have certain abnormal substances (inhibitors) that make it hard for blood to thicken (clot). Therefore, these people may bleed longer after surgery/injury or may bleed suddenly (often in the joints/muscles). This medication stops these inhibitors and allows the blood to clot so that you can stop bleeding. This medication also contains several different substances (factors) needed for the blood to clot.



This medication should not be used to treat other types of factor deficiencies (e.g., factors II, VII, VIII, IX, X).

How To Use Feiba VH Immuno IV

This medication is given slowly by injection into a vein by a health care professional. Health care professionals must follow all the manufacturer's instructions for properly mixing and giving this drug. Before mixing, warm the medication to room temperature. Do not refrigerate the solution after mixing. If you have any questions about using this medication properly, consult your doctor or pharmacist.

Dosage is based on your medical condition (e.g., amount and location of bleeding), weight, and response to treatment.

Tell your doctor if your condition persists or worsens.

Next Sectionchevron
Dosage and Storage




HONcode logo
We comply with the HONcode standard for health trust worthy information: verify here.
More info from:

HealthCentral.com





Rheumatoid Arthritis Quiz!

Rheumatoid arthritis x-ray knee

Do you have the facts straight on RA? Test your knowledge!

More

HealthCentral.com
Health Sites


view more conditions
Free Newsletters

Find a Therapist
Enter Zip Code

Powered by Psychology Today
PR Newswire
advertisement